Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07511062 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
Axatilimab combined with Decitabine/Venetoclax for the treatment of TP53-mutated/deleted AML patients
Trial Details
NCT Number NCT07511062
Lead Sponsor Northside Hospital, Inc.
Collaborators: Incyte Corporation
Conditions
(from sponsor)
Acute Myeloid Leukemia, TP53 Gene Mutation
Related terms Leukemia, Myeloid, Acute
Enrollment 32 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov